ATF4 and glioblastoma: The results showed that ATF4 gene silencing significantly attenuated the TMZ resistance, as evidenced by decreases in GBM cell viability (Fig. S3B) and increases in apoptotic GBM cells with TMZ treatment (Figs. 2D and S3C).